AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 22, 2011
30016_dirs_2011-02-22_cf9ba8a2-630f-4593-aaa4-39a0f4a8dfd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-17
Reporting Person: POLEWACZYK JAMES F (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-17 | Common Stock | M | 5265 | $56.9500 | Acquired | 8272 | Direct |
| 2011-02-17 | Common Stock | M | 8000 | $34.37 | Acquired | 16272 | Direct |
| 2011-02-17 | Common Stock | M | 2000 | $53.31 | Acquired | 18272 | Direct |
| 2011-02-17 | Common Stock | M | 3603 | $56.95 | Acquired | 21875 | Direct |
| 2011-02-17 | Common Stock | S | 12000 | $77.5764 | Disposed | 9875 | Direct |
| 2011-02-17 | Common Stock | S | 5236 | $77.6623 | Disposed | 4639 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-17 | Incentive Stock Option (right to buy) | $56.95 | M | 5265 | Disposed | 2015-02-13 | Common Stock (5265) | Direct |
| 2011-02-17 | Non-Qualified Stock Option (right to buy) | $34.37 | M | 8000 | Disposed | 2016-02-13 | Common Stock (8000) | Direct |
| 2011-02-17 | Non-Qualified Stock Option (right to buy) | $53.31 | M | 2000 | Disposed | 2017-02-13 | Common Stock (2000) | Direct |
| 2011-02-17 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 3603 | Disposed | 2015-02-13 | Common Stock (3603) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.50 to $77.72, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.63 to $77.695, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
F4: Grant of options to buy shares of common stock becomes exercisable as to 4,149 shares on 02/14/2010, 02/14/2011, 02/14/2012, 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
F5: Grant of options to buy shares of common stock becomes exercisable as to 2,707 shares on 02/14/2011 and 02/14/2012, 2,706 shares on 02/14/2013 and 02/14/2014, and the remaining 831 shares on 02/14/2015.
F6: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.